NJ State Employees Deferred Compensation Plan’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
2022
Q3
$3.1M Hold
2022
Q2
$2.99M Hold
2022
Q1
$2.43M Hold
2021
Q4
$2.83M Hold
2021
Q3
$2.85M Hold
2021
Q2
$1.99M Hold
2021
Q1
$1.4M Buy
2020
Q4
$1.29M Hold
2020
Q3
$975K Hold
2020
Q2
$1.1M Hold
2020
Q1
$510K Hold
2019
Q4
$817K Hold
2019
Q3
$626K Buy
2019
Q2
$263K Buy